Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Revenue

Burning Rock Biotech had revenue of 128.64M CNY in the quarter ending September 30, 2024, with 0.85% growth. This brings the company's revenue in the last twelve months to 510.89M, down -8.54% year-over-year. In the year 2023, Burning Rock Biotech had annual revenue of 537.44M, down -4.58%.

• Revenue (ttm): 510.89M CNY
• Revenue Growth: -8.54%
• P/S Ratio: 1.01
• Revenue / Employee: 649,981 CNY
• Employees: 786
• Market Cap: 73.27M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	537.44M	-25.80M	-4.58%
Dec 31, 2022	563.24M	55.38M	10.90%
Dec 31, 2021	507.86M	77.96M	18.13%
Dec 31, 2020	429.90M	48.23M	12.64%
Dec 31, 2019	381.68M	172.81M	82.74%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.